Page 1 of Clinical Trials for Drug Linagliptin, 37 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment
Last Updated: May 2, 2012
Condition(s): Diabetes Mellitus, Type 2
2
Completed
Linagliptin Open Label Comprehensive Safety Trial
Last Updated: March 7, 2012
Condition(s): Diabetes Mellitus, Type 2
3
Completed
Rel. BA of BI 10773/Linagliptin FDC Tbl, Comparison With Mono-components, With a Second FDC Tablet and Influence of Food
Last Updated: June 1, 2011
Condition(s): Healthy
4
Active, not recruiting
Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control
Last Updated: May 2, 2012
Condition(s): Diabetes Mellitus, Type 2
5
Recruiting
30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by 54 Week Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes
Last Updated: April 4, 2012
Condition(s): Diabetes Mellitus, Type 2
6
Completed
Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
7
Recruiting
Finding a Safe and Effective Dose of Linagliptin in Peadiatric Patients With Type 2 Diabetes
Last Updated: May 2, 2012
Condition(s): Diabetes Mellitus, Type 2
8
Recruiting
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
Last Updated: May 2, 2012
Condition(s): Diabetes Mellitus, Type 2
9
Completed
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study
Last Updated: March 7, 2012
Condition(s): Diabetes Mellitus, Type 2
10
Completed
Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic Patients
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
11
Completed
A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
12
Completed
Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2
13
Completed
Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components
Last Updated: October 19, 2011
Condition(s): Healthy
14
Recruiting
Linaglitpin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes
Last Updated: May 2, 2012
Condition(s): Diabetes Mellitus, Type 2
15
Completed
Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet
Last Updated: May 2, 2012
Condition(s): Diabetes Mellitus, Type 2
16
Completed
Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid
Last Updated: October 19, 2011
Condition(s): Diabetes Mellitus, Type 2
17
Recruiting
Bioequivalence of Metformin Under Fed Conditions After Administration of Linagliptin / Metformin Fixed Dose Combination Tablet and Single Tablets
Last Updated: May 2, 2012
Condition(s): Healthy
18
Recruiting
Efficacy and Safety of BI 10773/BI 1356 Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients
Last Updated: May 2, 2012
Condition(s): Diabetes Mellitus, Type 2
19
Recruiting
Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control
Last Updated: May 2, 2012
Condition(s): Diabetes Mellitus, Type 2
20
Completed
Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 2

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Linagliptin

Page 1 of Clinical Trials for Drug Linagliptin, 37 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About